A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase. / Kristensen, Kristian Kølby; Midtgaard, Søren Roi; Mysling, Simon; Kovrov, Oleg; Hansen, Lars Bo; Skar-Gislinge, Nicholas; Beigneux, Anne P.; Kragelund, Birthe Brandt; Olivecrona, Gunilla; Young, Stephen G.; Jørgensen, Thomas J. D.; Fong, Loren G.; Ploug, Michael.

I: Proceedings of the National Academy of Sciences of the United States of America, Bind 115, Nr. 26, 2018, s. E6020-E6029.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Kristensen, KK, Midtgaard, SR, Mysling, S, Kovrov, O, Hansen, LB, Skar-Gislinge, N, Beigneux, AP, Kragelund, BB, Olivecrona, G, Young, SG, Jørgensen, TJD, Fong, LG & Ploug, M 2018, 'A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase', Proceedings of the National Academy of Sciences of the United States of America, bind 115, nr. 26, s. E6020-E6029. https://doi.org/10.1073/pnas.1806774115

APA

Kristensen, K. K., Midtgaard, S. R., Mysling, S., Kovrov, O., Hansen, L. B., Skar-Gislinge, N., Beigneux, A. P., Kragelund, B. B., Olivecrona, G., Young, S. G., Jørgensen, T. J. D., Fong, L. G., & Ploug, M. (2018). A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase. Proceedings of the National Academy of Sciences of the United States of America, 115(26), E6020-E6029. https://doi.org/10.1073/pnas.1806774115

Vancouver

Kristensen KK, Midtgaard SR, Mysling S, Kovrov O, Hansen LB, Skar-Gislinge N o.a. A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase. Proceedings of the National Academy of Sciences of the United States of America. 2018;115(26):E6020-E6029. https://doi.org/10.1073/pnas.1806774115

Author

Kristensen, Kristian Kølby ; Midtgaard, Søren Roi ; Mysling, Simon ; Kovrov, Oleg ; Hansen, Lars Bo ; Skar-Gislinge, Nicholas ; Beigneux, Anne P. ; Kragelund, Birthe Brandt ; Olivecrona, Gunilla ; Young, Stephen G. ; Jørgensen, Thomas J. D. ; Fong, Loren G. ; Ploug, Michael. / A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase. I: Proceedings of the National Academy of Sciences of the United States of America. 2018 ; Bind 115, Nr. 26. s. E6020-E6029.

Bibtex

@article{5f14c6758c9e4036b301410fa39f0780,
title = "A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase",
abstract = "The intravascular processing of triglyceride-rich lipoproteins depends on lipoprotein lipase (LPL) and GPIHBP1, a membrane protein of endothelial cells that binds LPL within the subendothelial spaces and shuttles it to the capillary lumen. In the absence of GPIHBP1, LPL remains mislocalized within the subendothelial spaces, causing severe hypertriglyceridemia (chylomicronemia). The N-terminal domain of GPIHBP1, an intrinsically disordered region (IDR) rich in acidic residues, is important for stabilizing LPL's catalytic domain against spontaneous and ANGPTL4-catalyzed unfolding. Here, we define several important properties of GPIHBP1's IDR. First, a conserved tyrosine in the middle of the IDR is posttranslationally modified by O-sulfation; this modification increases both the affinity of GPIHBP1-LPL interactions and the ability of GPIHBP1 to protect LPL against ANGPTL4-catalyzed unfolding. Second, the acidic IDR of GPIHBP1 increases the probability of a GPIHBP1-LPL encounter via electrostatic steering, increasing the association rate constant (kon) for LPL binding by >250-fold. Third, we show that LPL accumulates near capillary endothelial cells even in the absence of GPIHBP1. In wild-type mice, we expect that the accumulation of LPL in close proximity to capillaries would increase interactions with GPIHBP1. Fourth, we found that GPIHBP1's IDR is not a key factor in the pathogenicity of chylomicronemia in patients with the GPIHBP1 autoimmune syndrome. Finally, based on biophysical studies, we propose that the negatively charged IDR of GPIHBP1 traverses a vast space, facilitating capture of LPL by capillary endothelial cells and simultaneously contributing to GPIHBP1's ability to preserve LPL structure and activity.",
author = "Kristensen, {Kristian K{\o}lby} and Midtgaard, {S{\o}ren Roi} and Simon Mysling and Oleg Kovrov and Hansen, {Lars Bo} and Nicholas Skar-Gislinge and Beigneux, {Anne P.} and Kragelund, {Birthe Brandt} and Gunilla Olivecrona and Young, {Stephen G.} and J{\o}rgensen, {Thomas J. D.} and Fong, {Loren G.} and Michael Ploug",
year = "2018",
doi = "10.1073/pnas.1806774115",
language = "English",
volume = "115",
pages = "E6020--E6029",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "The National Academy of Sciences of the United States of America",
number = "26",

}

RIS

TY - JOUR

T1 - A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase

AU - Kristensen, Kristian Kølby

AU - Midtgaard, Søren Roi

AU - Mysling, Simon

AU - Kovrov, Oleg

AU - Hansen, Lars Bo

AU - Skar-Gislinge, Nicholas

AU - Beigneux, Anne P.

AU - Kragelund, Birthe Brandt

AU - Olivecrona, Gunilla

AU - Young, Stephen G.

AU - Jørgensen, Thomas J. D.

AU - Fong, Loren G.

AU - Ploug, Michael

PY - 2018

Y1 - 2018

N2 - The intravascular processing of triglyceride-rich lipoproteins depends on lipoprotein lipase (LPL) and GPIHBP1, a membrane protein of endothelial cells that binds LPL within the subendothelial spaces and shuttles it to the capillary lumen. In the absence of GPIHBP1, LPL remains mislocalized within the subendothelial spaces, causing severe hypertriglyceridemia (chylomicronemia). The N-terminal domain of GPIHBP1, an intrinsically disordered region (IDR) rich in acidic residues, is important for stabilizing LPL's catalytic domain against spontaneous and ANGPTL4-catalyzed unfolding. Here, we define several important properties of GPIHBP1's IDR. First, a conserved tyrosine in the middle of the IDR is posttranslationally modified by O-sulfation; this modification increases both the affinity of GPIHBP1-LPL interactions and the ability of GPIHBP1 to protect LPL against ANGPTL4-catalyzed unfolding. Second, the acidic IDR of GPIHBP1 increases the probability of a GPIHBP1-LPL encounter via electrostatic steering, increasing the association rate constant (kon) for LPL binding by >250-fold. Third, we show that LPL accumulates near capillary endothelial cells even in the absence of GPIHBP1. In wild-type mice, we expect that the accumulation of LPL in close proximity to capillaries would increase interactions with GPIHBP1. Fourth, we found that GPIHBP1's IDR is not a key factor in the pathogenicity of chylomicronemia in patients with the GPIHBP1 autoimmune syndrome. Finally, based on biophysical studies, we propose that the negatively charged IDR of GPIHBP1 traverses a vast space, facilitating capture of LPL by capillary endothelial cells and simultaneously contributing to GPIHBP1's ability to preserve LPL structure and activity.

AB - The intravascular processing of triglyceride-rich lipoproteins depends on lipoprotein lipase (LPL) and GPIHBP1, a membrane protein of endothelial cells that binds LPL within the subendothelial spaces and shuttles it to the capillary lumen. In the absence of GPIHBP1, LPL remains mislocalized within the subendothelial spaces, causing severe hypertriglyceridemia (chylomicronemia). The N-terminal domain of GPIHBP1, an intrinsically disordered region (IDR) rich in acidic residues, is important for stabilizing LPL's catalytic domain against spontaneous and ANGPTL4-catalyzed unfolding. Here, we define several important properties of GPIHBP1's IDR. First, a conserved tyrosine in the middle of the IDR is posttranslationally modified by O-sulfation; this modification increases both the affinity of GPIHBP1-LPL interactions and the ability of GPIHBP1 to protect LPL against ANGPTL4-catalyzed unfolding. Second, the acidic IDR of GPIHBP1 increases the probability of a GPIHBP1-LPL encounter via electrostatic steering, increasing the association rate constant (kon) for LPL binding by >250-fold. Third, we show that LPL accumulates near capillary endothelial cells even in the absence of GPIHBP1. In wild-type mice, we expect that the accumulation of LPL in close proximity to capillaries would increase interactions with GPIHBP1. Fourth, we found that GPIHBP1's IDR is not a key factor in the pathogenicity of chylomicronemia in patients with the GPIHBP1 autoimmune syndrome. Finally, based on biophysical studies, we propose that the negatively charged IDR of GPIHBP1 traverses a vast space, facilitating capture of LPL by capillary endothelial cells and simultaneously contributing to GPIHBP1's ability to preserve LPL structure and activity.

U2 - 10.1073/pnas.1806774115

DO - 10.1073/pnas.1806774115

M3 - Journal article

C2 - 29899144

VL - 115

SP - E6020-E6029

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 26

ER -

ID: 199753659